121 related articles for article (PubMed ID: 9351898)
1. Heterologous expression of human drug-metabolizing enzymes.
Guengerich FP; Parikh A; Johnson EF; Richardson TH; von Wachenfeldt C; Cosme J; Jung F; Strassburg CP; Manns MP; Tukey RH; Pritchard M; Fournel-Gigleux S; Burchell B
Drug Metab Dispos; 1997 Nov; 25(11):1234-41. PubMed ID: 9351898
[TBL] [Abstract][Full Text] [Related]
2. Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolism.
Halpert JR; Domanski TL; Adali O; Biagini CP; Cosme J; Dierks EA; Johnson EF; Jones JP; Ortiz de Montellano P; Philpot RM; Sibbesen O; Wyatt WK; Zheng Z
Drug Metab Dispos; 1998 Dec; 26(12):1223-31. PubMed ID: 9860932
[TBL] [Abstract][Full Text] [Related]
3. New applications of bacterial systems to problems in toxicology.
Guengerich FP; Gillam EM; Shimada T
Crit Rev Toxicol; 1996 Sep; 26(5):551-83. PubMed ID: 8891430
[TBL] [Abstract][Full Text] [Related]
4. Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney.
Cummings BS; Lasker JM; Lash LH
J Pharmacol Exp Ther; 2000 May; 293(2):677-85. PubMed ID: 10773044
[TBL] [Abstract][Full Text] [Related]
5. Drug metabolism by Escherichia coli expressing human cytochromes P450.
Parikh A; Gillam EM; Guengerich FP
Nat Biotechnol; 1997 Aug; 15(8):784-8. PubMed ID: 9255795
[TBL] [Abstract][Full Text] [Related]
6. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.
Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG
Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260
[TBL] [Abstract][Full Text] [Related]
7. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
Avent KM; DeVoss JJ; Gillam EM
Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
11. Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes.
Zöllner A; Buchheit D; Meyer MR; Maurer HH; Peters FT; Bureik M
Bioanalysis; 2010 Jul; 2(7):1277-90. PubMed ID: 21083240
[TBL] [Abstract][Full Text] [Related]
12. Pre- and postweaning development of drug-metabolizing enzyme activities in small intestine and liver of rats.
de Waziers I; Boisset M; Atteba S
Drug Metab Dispos; 1988; 16(2):310-5. PubMed ID: 2898352
[TBL] [Abstract][Full Text] [Related]
13. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
[TBL] [Abstract][Full Text] [Related]
14. Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs.
Guengerich FP; Hosea NA; Parikh A; Bell-Parikh LC; Johnson WW; Gillam EM; Shimada T
Drug Metab Dispos; 1998 Dec; 26(12):1175-8. PubMed ID: 9860923
[TBL] [Abstract][Full Text] [Related]
15. Expression and coupling of human cytochrome P450 2E1 and NADPH-cytochrome P450 oxidoreductase in dual expression and co-infection systems with baculovirus in insect cells.
Wang MH; Patten CJ; Yang GY; Paranawithana SR; Tan Y; Yang CS
Arch Biochem Biophys; 1996 Oct; 334(2):380-8. PubMed ID: 8900414
[TBL] [Abstract][Full Text] [Related]
16. Age- and gender-related variations in the activities of drug-metabolizing and antioxidant enzymes in the white-footed mouse (Peromyscus leucopus).
Guo Z; Wang M; Tian G; Burger J; Gochfeld M; Yang CS
Growth Dev Aging; 1993; 57(2):85-100. PubMed ID: 8495997
[TBL] [Abstract][Full Text] [Related]
17. Molecular regulation of genes encoding xenobiotic-metabolizing enzymes: mechanisms involving endogenous factors.
Hines RN; Luo Z; Cresteil T; Ding X; Prough RA; Fitzpatrick JL; Ripp SL; Falkner KC; Ge NL; Levine A; Elferink CJ
Drug Metab Dispos; 2001 May; 29(5):623-33. PubMed ID: 11302926
[TBL] [Abstract][Full Text] [Related]
18. Expression of drug-metabolizing enzymes.
Guengerich FP; Parikh A
Curr Opin Biotechnol; 1997 Oct; 8(5):623-8. PubMed ID: 9353222
[TBL] [Abstract][Full Text] [Related]
19. Formation of indigo by recombinant mammalian cytochrome P450.
Gillam EM; Aguinaldo AM; Notley LM; Kim D; Mundkowski RG; Volkov AA; Arnold FH; Soucek P; DeVoss JJ; Guengerich FP
Biochem Biophys Res Commun; 1999 Nov; 265(2):469-72. PubMed ID: 10558891
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin A deficiency on hepatic and intestinal drug metabolizing enzymes in rats.
Gupta PH; Mehta S; Mehta SK
Biochem Int; 1989 Jul; 19(1):123-33. PubMed ID: 2505773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
